University of Connecticut Health Center (UCHC)
Farmington, Connecticut, 06030-3705, United States
Location status: Recruiting
NCT Number: NCT01619553
Keloids have a strong genetic component. The goal of this study is to identify genes and regulatory elements on chromosomes that are the cause for keloids or contribute to keloid scarring.
Interested in participating?
Request InfoAll sexes
Observational
Farmington, Connecticut, 06030-3705, United States
Location status: Recruiting
Keloids are scars that keep growing beyond the border of the original wound. They typically persist for several years, expand for an extensive period of time and are sometimes called benign tumors. Keloids often have a lumpy surface and are often tender, itchy or inflamed around the growing border.
Keloids in most keloid patients do not run in the family. In the inheritable form of keloids it is possible that there is one major gene mutation that puts family members at risk for developing keloids. There may be other variations in the DNA (DNA makes up the chromosomes) that determine whether keloids become large and aggressive or stay small and without many symptoms.
For this study we will:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at time of identification
The goal is to identify relevant genes or genetic elements that cause the disease or contribute to the disease progression and severity.
Contact information is provided by the study sponsor or research team.
UConn Health
Other
Identification of Genetic Variants That Contribute to Keloid Formation in Families and Isolated Cases.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03795116
Cicatrix, Cicatrix, Hypertrophic
Brooklyn, New York, United States
View Trial DetailsNCT02630303
Cicatrix, Collagen Diseases
Mather, California, United States
View Trial DetailsNCT01423981
Cicatrix, Cicatrix, Hypertrophic
New York, United States
View Trial DetailsNCT07673484
Allergic Contact Dermatitis, Cicatrix
Küçükçekmece, Istanbul, Turkey (Türkiye)
View Trial Details